Loneliness and regret are key drivers of mental health distress among people with amyotrophic lateral sclerosis (ALS), according…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
People with amyotrophic lateral sclerosis (ALS) who have a history of strenuous exercise tend to develop the disease earlier…
Analyses of vocal recordings using artificial intelligence (AI) may aid in the diagnosis of amyotrophic lateral sclerosis (ALS), particularly…
New analyses of data from two Phase 2 clinical trials and observational studies suggest that changes in blood levels of…
People who sustain a traumatic brain injury (TBI) are more likely to die within two years from amyotrophic lateral…
Treatment with a novel one-time gene therapy improved motor function and extended survival in a mouse model of amyotrophic…
A panel of 19 blood proteins may help estimate when symptoms of amyotrophic lateral sclerosis (ALS) will emerge in people…
For people serving in the U.S. armed forces, the risk of developing amyotrophic lateral sclerosis (ALS) varies by military…
Mutations in the NEK1 gene — a major genetic cause of amyotrophic lateral sclerosis (ALS) — can disrupt the molecular…
Abnormal levels of certain fatty molecules in the body — which are broken down by metabolism to support daily functions…